47.89
price down icon0.50%   -0.24
pre-market  プレマーケット:  48.71   0.82   +1.71%
loading
前日終値:
$48.13
開ける:
$47.87
24時間の取引高:
143.80K
Relative Volume:
0.47
時価総額:
$894.58M
収益:
$299.77M
当期純損益:
$364.23M
株価収益率:
2.5581
EPS:
18.7211
ネットキャッシュフロー:
$79.27M
1週間 パフォーマンス:
+4.45%
1か月 パフォーマンス:
+6.16%
6か月 パフォーマンス:
+83.28%
1年 パフォーマンス:
+58.16%
1日の値動き範囲:
Value
$47.00
$48.14
1週間の範囲:
Value
$45.24
$49.02
52週間の値動き範囲:
Value
$24.95
$52.24

Rigel Pharmaceuticals Stock (RIGL) Company Profile

Name
名前
Rigel Pharmaceuticals
Name
セクター
Healthcare (1068)
Name
電話
650-624-1100
Name
住所
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Name
職員
174
Name
Twitter
@rigelpharma
Name
次回の収益日
2026-11-03
Name
最新のSEC提出書
Name
RIGL's Discussions on Twitter

Compare RIGL vs VRTX, REGN, MRNA, ARGX, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
RIGL icon
RIGL
Rigel Pharmaceuticals
47.89 894.58M 299.77M 364.23M 79.27M 18.72
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
522.38 132.40B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
796.02 81.95B 14.92B 4.42B 3.79B 41.04
MRNA icon
MRNA
Moderna Inc
194.82 77.78B 2.23B -3.19B -1.60B -8.1462
ARGX icon
ARGX
Argen X Se Adr
962.22 60.20B 4.16B 1.29B 734.26M 19.58
RVMD icon
RVMD
Revolution Medicines Inc
199.86 42.84B 742.00K -1.37B -1.07B -7.0731

Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-11-05 アップグレード Jefferies Hold → Buy
2023-04-03 再開されました Piper Sandler Neutral
2022-06-09 ダウングレード Citigroup Buy → Neutral
2022-06-08 ダウングレード Cantor Fitzgerald Overweight → Neutral
2022-06-08 ダウングレード Piper Sandler Overweight → Neutral
2022-03-23 開始されました B. Riley Securities Neutral
2020-11-09 ダウングレード JP Morgan Overweight → Neutral
2019-11-15 再開されました Cantor Fitzgerald Overweight
2019-09-26 再開されました JP Morgan Overweight
2019-03-01 繰り返されました Cantor Fitzgerald Overweight
2018-08-27 開始されました Citigroup Buy
2018-05-02 繰り返されました Cantor Fitzgerald Overweight
2017-12-21 再開されました Piper Jaffray Overweight
2017-12-15 開始されました Cantor Fitzgerald Overweight
2017-11-06 再開されました H.C. Wainwright Buy
2017-03-09 繰り返されました H.C. Wainwright Buy
2016-08-31 繰り返されました H.C. Wainwright Buy
2016-08-30 繰り返されました Piper Jaffray Overweight
2016-07-13 開始されました H.C. Wainwright Buy
2016-06-13 開始されました Piper Jaffray Overweight
2016-04-22 アップグレード JP Morgan Neutral → Overweight
2013-04-08 繰り返されました Stifel Buy
2012-11-29 開始されました UBS Neutral
2012-11-06 繰り返されました Oppenheimer Outperform
2012-03-26 開始されました Canaccord Genuity Hold
2010-12-10 ダウングレード MP Advisors Outperform → Market Perform
すべてを表示

Rigel Pharmaceuticals (RIGL) 最新ニュース

pulisher
Sep 23, 2026

Rigel Pharmaceuticals, Inc. (RIGL) Options ChainYahoo Finance - Yahoo! Finance Canada

Sep 23, 2026
pulisher
Sep 15, 2026

Rigel Pharmaceuticals, Inc. (RIGL) Presents at H.C. Wainwright 28th Annual Global Investment ConferenceSlideshow (NASDAQ:RIGL) 2026-09-15 - Seeking Alpha

Sep 15, 2026
pulisher
Sep 15, 2026

Rigel Pharmaceuticals at H.C. Wainwright conference: growth plan broadens - Investing.com

Sep 15, 2026
pulisher
Sep 15, 2026

Rigel Pharmaceuticals at H.C. Wainwright conference: growth plan broadens By Investing.com - Investing.com Australia

Sep 15, 2026
pulisher
Sep 15, 2026

Rigel Pharmaceuticals, Inc. (RIGL) Presents at 12th Annual Cantor Fitzgerald Global Healthcare ConferenceSlideshow (NASDAQ:RIGL) 2026-09-15 - Seeking Alpha

Sep 15, 2026
pulisher
Sep 15, 2026

Precision Trading with Rigel Pharmaceuticals Inc. (RIGL) Risk Zones - news.stocktradersdaily.com

Sep 15, 2026
pulisher
Sep 11, 2026

RIGL Stock Jumps 15%, Short Interest Surges To Record High – Why Is Retail Eyeing A Further 40% Upside? - Stocktwits

Sep 11, 2026
pulisher
Sep 10, 2026

Rigel Pharmaceuticals at Cantor conference: veppanu launch leads growth push - Investing.com Nigeria

Sep 10, 2026
pulisher
Sep 10, 2026

Rigel Pharmaceuticals at Cantor conference: veppanu launch leads growth push By Investing.com - Investing.com South Africa

Sep 10, 2026
pulisher
Sep 09, 2026

Rigel Pharmaceuticals (RIGL) Institutional Ownership 2026 $RIGL - MarketBeat

Sep 09, 2026
pulisher
Sep 08, 2026

H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $85 - Moomoo

Sep 08, 2026
pulisher
Sep 04, 2026

Trading the Move, Not the Narrative: (RIGL) Edition - Stock Traders Daily

Sep 04, 2026
pulisher
Sep 04, 2026

EVP & Chief Financial Officer At Rigel Pharmaceuticals Exercises Options Worth $123K - Benzinga

Sep 04, 2026
pulisher
Sep 03, 2026

Rigel (NASDAQ: RIGL) CCO now holds 61,622 shares - Stock Titan

Sep 03, 2026
pulisher
Sep 03, 2026

Rigel Pharmaceuticals (RIGL) CEO returns 2,424 shares to issuer - Stock Titan

Sep 03, 2026
pulisher
Sep 03, 2026

Rigel Pharmaceuticals (NASDAQ: RIGL) insider now holds 50,559 shares - Stock Titan

Sep 03, 2026
pulisher
Sep 02, 2026

Rigel Pharmaceuticals CFO to present at three m... - Pluang

Sep 02, 2026
pulisher
Sep 02, 2026

Rigel to Participate in Upcoming September Investor Conferences - PR Newswire

Sep 02, 2026
pulisher
Sep 02, 2026

Rigel Pharmaceuticals (RIGL) CFO exercises options and uses shares to cover taxes - Stock Titan

Sep 02, 2026
pulisher
Aug 31, 2026

Rigel Pharmaceuticals Inc. (RIGL) Peer Comparison – Compare with Others - Value Research

Aug 31, 2026
pulisher
Aug 20, 2026

Rigel (RIGL) Results Breakdown: EPS Exceeds Its Estimate for the Current Session; Market Reaction: Shares Finish 3.64% Down in Latest TradingSurprise Factor Analysis - Vinanet

Aug 20, 2026
pulisher
Aug 19, 2026

Rigel Pharmaceuticals (NASDAQ:RIGL) Rating Increased to Hold at Zacks Research - MarketBeat

Aug 19, 2026
pulisher
Aug 18, 2026

HC Wainwright Analysts Increase Earnings Estimates for RIGL - MarketBeat

Aug 18, 2026
pulisher
Aug 17, 2026

Rigel Pharmaceuticals Inc (RIGL) (Q2 2026) Earnings Call Highlig - GuruFocus

Aug 17, 2026
pulisher
Aug 17, 2026

Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $49 - Moomoo

Aug 17, 2026
pulisher
Aug 17, 2026

RIGL Maintains Neutral Rating -- Price Target Raised to $49.00 b - GuruFocus

Aug 17, 2026
pulisher
Aug 16, 2026

Rigel Pharmaceuticals (RIGL) Stock Sees Fair Value Lift As Veppanu Launch Adds Growth Hope - Yahoo Finance

Aug 16, 2026
pulisher
Aug 15, 2026

Rigel Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript - GuruFocus

Aug 15, 2026
pulisher
Aug 15, 2026

(RIGL) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Aug 15, 2026
pulisher
Aug 14, 2026

RIGL Maintained by HC Wainwright & Co. -- Price Target Raised to $85 - GuruFocus

Aug 14, 2026
pulisher
Aug 14, 2026

Armistice Capital (RIGL) reports 1.67M Rigel Pharmaceuticals shares in 13G/A - Stock Titan

Aug 14, 2026
pulisher
Aug 13, 2026

Rigel announces availability of Veppanu in the USA - The Pharma Letter

Aug 13, 2026
pulisher
Aug 13, 2026

Rigel Says Breast Cancer Drug Veppanu Now Available in US, Puerto Rico - marketscreener.com

Aug 13, 2026
pulisher
Aug 13, 2026

Rigel Pharmaceuticals (RIGL): Soleus Capital group discloses 9.9% ownership stake - Stock Titan

Aug 13, 2026
pulisher
Aug 13, 2026

Rigel's VEPPANU Is Now Available for Certain Advanced Breast Cancers - Stock Titan

Aug 13, 2026
pulisher
Aug 11, 2026

Rigel Pharmaceuticals, Inc. (RIGL) Latest Stock News & Headlines - finance.yahoo.com

Aug 11, 2026
pulisher
Aug 11, 2026

Rigel (RIGL) Q2 2026 Earnings Call Transcript - The Globe and Mail

Aug 11, 2026
pulisher
Aug 11, 2026

Rigel Pharmaceuticals (RIGL) Short Interest & Short Float | Updated Aug 2026 $RIGL - MarketBeat

Aug 11, 2026
pulisher
Aug 10, 2026

Rigel Pharmaceuticals, Inc. $RIGL Shares Purchased by Dimensional Fund Advisors LP - MarketBeat

Aug 10, 2026
pulisher
Aug 10, 2026

Rigel Pharmaceuticals (RIGL) Advances 3.71% to $41.66 as Bullish Momentum Targets $43.74 ResistanceBollinger Band - dars.gov.et

Aug 10, 2026
pulisher
Aug 08, 2026

Janus Henderson Group PLC Boosts Position in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat

Aug 08, 2026
pulisher
Aug 07, 2026

Rigel Pharmaceuticals Inc (RIGL) Stock News Today - TradingKey

Aug 07, 2026
pulisher
Aug 07, 2026

Rigel Pharmaceuticals Inc (RIGL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 07, 2026
pulisher
Aug 07, 2026

HC Wainwright Issues Pessimistic Estimate for RIGL Earnings - MarketBeat

Aug 07, 2026
pulisher
Aug 07, 2026

Pacer Advisors Inc. Purchases 48,882 Shares of Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat

Aug 07, 2026
pulisher
Aug 06, 2026

Cantor Fitzgerald Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $43 - 富途牛牛

Aug 06, 2026
pulisher
Aug 06, 2026

HC Wainwright Issues Pessimistic Forecast for RIGL Earnings - MarketBeat

Aug 06, 2026
pulisher
Aug 06, 2026

Empowered Funds LLC Takes Position in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat

Aug 06, 2026
pulisher
Aug 06, 2026

Rigel Pharmaceuticals (RIGL) Stock Rally Runs Into Earnings Quality Doubts - simplywall.st

Aug 06, 2026
pulisher
Aug 05, 2026

Rigel Pharmaceuticals in-licenses Veppanu, targ... - Pluang

Aug 05, 2026
pulisher
Aug 05, 2026

Rigel Pharmaceuticals: A Four-Drug Company With A Clinical Catalyst Ahead (NASDAQ:RIGL) - Seeking Alpha

Aug 05, 2026

Rigel Pharmaceuticals (RIGL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$58.29
price up icon 1.11%
$36.13
price down icon 1.87%
$121.55
price up icon 2.71%
$249.59
price up icon 1.25%
ONC ONC
$359.97
price down icon 1.38%
$199.86
price up icon 4.78%
大文字化:     |  ボリューム (24 時間):